Select One Of The Following Organizations Below To Review

Select One Of The Following Organizations Below To Review Data About 3

Select one of the following organizations below to review data about 3 specific diseases in a country that you have chosen to learn more about, and report the statistical outcome over the last 3 years: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), Healthy People 2020. Then, complete the following: Briefly explain each of the 3 diseases (e.g., whether it is communicable or noncommunicable). Identify the country you have chosen to view (e.g., the United States, Canada, England, or Russia). Report the statistical outcome for the last 3 years. Explain what population is most at risk and how each challenge will impact the population. Once the data have been reviewed, explain 2 factors that will influence a quality-improvement process over the next few years.

Paper For Above instruction

The analysis selected to review is based on data from the Centers for Disease Control and Prevention (CDC) concerning three significant diseases within the United States over the past three years. This report aims to describe each disease, assess recent statistical trends, identify populations at most risk, and evaluate the prospective influence on public health strategies, especially quality improvement initiatives.

Description of the Diseases

The first disease is influenza, a highly contagious viral infection that primarily affects the respiratory system and is classified as a communicable disease. Despite the availability of vaccines, influenza remains a significant public health concern due to annual outbreaks and varying vaccine efficacy (CDC, 2021). The second disease is type 2 diabetes mellitus, a noncommunicable metabolic disorder characterized by insulin resistance and chronic hyperglycemia. It is associated with lifestyle factors and genetic predispositions and has been steadily rising in prevalence (American Diabetes Association, 2022). The third disease is opioid use disorder, a noncommunicable mental health condition linked to the misuse of opioids, leading to significant morbidity and mortality (CDC, 2020).

Statistical Outcomes Over the Last Three Years

Data from the CDC indicates that influenza vaccination coverage among the U.S. population increased marginally from 48.4% in 2020 to 51.8% in 2022 (CDC, 2022). Reported influenza cases and hospitalizations declined slightly in 2021 but surged again in 2022, reflecting seasonal variations and vaccine effectiveness (CDC, 2022). Similarly, the prevalence of type 2 diabetes has continued to rise, with estimates indicating an increase from 34.2 million cases in 2019 to approximately 37.3 million in 2022 (CDC, 2023). Hospitalizations related to opioid overdose declined in 2021 but rebounded with 100,000 deaths in 2021 alone, demonstrating persistent challenges in managing the opioid epidemic (CDC, 2022).

Population at Most Risk and Impact of Challenges

High-risk populations for influenza include the elderly, children, healthcare workers, and individuals with chronic health conditions, due to their increased susceptibility and potential for severe outcomes (CDC, 2021). Those most affected by type 2 diabetes are often racial and ethnic minorities, such as African Americans and Hispanics, who experience disparities in access to healthcare and healthy lifestyle options (CDC, 2023). The opioid crisis predominantly impacts younger adults, economically disadvantaged populations, and those with co-occurring mental health disorders, exacerbating social and economic challenges (CDC, 2020). These health challenges place immense burdens on healthcare systems, increase mortality rates, reduce workforce productivity, and elevate societal costs.

Factors Influencing Future Quality-Improvement Processes

Two critical factors likely to influence quality improvement efforts include technological advancements in healthcare and policy reforms. Telemedicine and digital health records enhance disease monitoring and patient engagement, facilitating timely interventions and personalized care (Kellerman & Herold, 2020). Additionally, policy initiatives aimed at expanding healthcare access, improving vaccination coverage, and regulating prescription practices will significantly impact disease management (NASEM, 2021). Both factors support the development of more effective, equitable, and sustainable public health strategies to mitigate disease burdens over the coming years.

References

  • American Diabetes Association. (2022). Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Supplement 1), S1–S232.
  • Centers for Disease Control and Prevention. (2020). Opioid Overdose Prevention, National Institute on Drug Abuse. https://www.cdc.gov/drugoverdose/index.html
  • Centers for Disease Control and Prevention. (2021). Disease Burden of Influenza. https://www.cdc.gov/flu/about/burden/index.html
  • Centers for Disease Control and Prevention. (2022). Influenza Vaccination Coverage, United States, 2021-2022. https://www.cdc.gov/flu/fluvaxview/coverage-2022estimates.htm
  • Centers for Disease Control and Prevention. (2023). National Diabetes Statistics Report, 2023. https://www.cdc.gov/diabetes/data/statistics-report/index.html
  • Centers for Disease Control and Prevention. (2022). Annual Surveillance of Opioid Overdose Deaths. https://www.cdc.gov/drugoverdose/data/statedeaths.html
  • Kellerman, A., & Herold, J. (2020). Telemedicine and Digital Health in Public Health. Journal of Medical Internet Research, 22(5), e18216.
  • NASEM. (2021). Advancing Health Equity Through Quality Improvement. National Academies of Sciences, Engineering, and Medicine.
  • World Health Organization. (2019). Vaccines and Immunization. https://www.who.int/health-topics/vaccines-and-immunization

Related Assignments